SeqOne
5 known investors
Find your way into SeqOne
Sign up to see every warm intro you have to SeqOne
- Paths you didn't know you had: your email and LinkedIn already hold routes to the SeqOne team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SeqOne provides a clinical genomics analysis platform for germline and somatic variant interpretation across panels, exomes, and genomes, supporting short and long-read sequencing. It offers tools such as a DiagAI variant-prioritization score and an automated data pipeline (SeqOne Flow), serving diagnostic labs and clinical genomics teams with a CE-IVD certified in vitro diagnostic medical device.
Founders & leadership

Investors · 5
How we know: PSL Innovation Fund's portfolio page · Not right? Tell us
How we know: funding news · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · funding news · press coverage · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountGrowthMay 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does SeqOne do?
- SeqOne provides a clinical genomics analysis platform for germline and somatic variant interpretation across panels, exomes, and genomes, supporting short and long-read sequencing. It offers tools such as a DiagAI variant-prioritization score and an automated data pipeline (SeqOne Flow), serving diagnostic labs and clinical genomics teams with a CE-IVD certified in vitro diagnostic medical device.
- Who founded SeqOne?
- SeqOne was founded by Nicolas Philippe.
- Who are SeqOne's investors?
- SeqOne's investors include Korys, Mérieux Equity Partners, PSL Innovation Fund, Supernova Invest, Elaia.

